A Comparison Of Markov Cohort And Discrete Event Simulation Models In Cost-Effectiveness Analysis Of Sorafenib And Everolimus In 3rd Line Metastatic Renal-Cell Carcinoma In The Czech Republic
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.2108
https://www.valueinhealthjournal.com/article/S1098-3015(17)32442-7/fulltext
Section Title :
Research on Methods Studies
Section Order :
1931
First Page :
A752
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32442-7&doi=10.1016/j.jval.2017.08.2108